{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:38:43Z","timestamp":1793597923174,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Z99 DE999999"],"award-info":[{"award-number":["Z99 DE999999"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jim.2017.02.001","type":"journal-article","created":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T14:31:59Z","timestamp":1486218719000},"page":"17-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Detection and monitoring PLA 2 R autoantibodies by LIPS in membranous nephropathy"],"prefix":"10.1016","volume":"444","author":[{"given":"Peter D.","family":"Burbelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Laurence H.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryl","family":"Waldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.jim.2017.02.001_bb0005","doi-asserted-by":"crossref","first-page":"8963","DOI":"10.1074\/jbc.270.15.8963","article-title":"The human 180-kDa receptor for secretory phospholipases A2. Molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization","volume":"270","author":"Ancian","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.jim.2017.02.001_bb0010","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2215\/CJN.10471013","article-title":"Association of anti-PLA(2)R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy","volume":"9","author":"Bech","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.jim.2017.02.001_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.jim.2017.02.001_bb0020","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1681\/ASN.2010111125","article-title":"Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy","volume":"22","author":"Beck","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.jim.2017.02.001_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061669","article-title":"An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor","volume":"8","author":"Behnert","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2017.02.001_bb0030","doi-asserted-by":"crossref","first-page":"143274","DOI":"10.1155\/2014\/143274","article-title":"Antiphospholipase A(2) receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy","volume":"2014","author":"Behnert","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jim.2017.02.001_bb0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1472-6750-5-22","article-title":"A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins","volume":"5","author":"Burbelo","year":"2005","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.jim.2017.02.001_bb0040","article-title":"Antibody profiling by luciferase immunoprecipitation systems (LIPS)","volume":"32","author":"Burbelo","year":"2009","journal-title":"J. Vis. Exp."},{"issue":"10","key":"10.1016\/j.jim.2017.02.001_bb0045","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/infdis\/jit667","article-title":"HIV antibody characterization as a method to quantify reservoir size during curative interventions","volume":"209","author":"Burbelo","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jim.2017.02.001_bb0050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.trsl.2014.08.006","article-title":"Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseases","volume":"165","author":"Burbelo","year":"2015","journal-title":"Transl. Res."},{"key":"10.1016\/j.jim.2017.02.001_bb0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cca.2013.03.015","article-title":"Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy","volume":"421","author":"Dahnrich","year":"2013","journal-title":"Clin. Chim. Acta"},{"issue":"13","key":"10.1016\/j.jim.2017.02.001_bb0060","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88782","article-title":"Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"1","author":"Ferre","year":"2016","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.jim.2017.02.001_bb0065","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2014050502","article-title":"Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy","volume":"26","author":"Fresquet","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.jim.2017.02.001_bb0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.ajkd.2010.01.008","article-title":"The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey","volume":"56","author":"Glassock","year":"2010","journal-title":"Am. J. Kidney Dis."},{"issue":"11","key":"10.1016\/j.jim.2017.02.001_bb0075","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1021\/cb3002478","article-title":"Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate","volume":"7","author":"Hall","year":"2012","journal-title":"ACS Chem. Biol."},{"issue":"6","key":"10.1016\/j.jim.2017.02.001_bb0080","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2215\/CJN.07210810","article-title":"Anti-phospholipase A(2) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy","volume":"6","author":"Hofstra","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.jim.2017.02.001_bb0085","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.2012030242","article-title":"Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy","volume":"23","author":"Hofstra","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.jim.2017.02.001_bb0090","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/ndt\/gfr247","article-title":"An immunofluorescence test for phospholipase-A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis","volume":"26","author":"Hoxha","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"7","key":"10.1016\/j.jim.2017.02.001_bb0095","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ki.2012.209","article-title":"Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy","volume":"82","author":"Hoxha","year":"2012","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.jim.2017.02.001_bb0100","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy","volume":"83","author":"Kanigicherla","year":"2013","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.jim.2017.02.001_bb0105","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1681\/ASN.2013121315","article-title":"Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy","volume":"26","author":"Kao","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.jim.2017.02.001_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160192","article-title":"Anti-HIV antibody responses and the HIV reservoir size during antiretroviral therapy","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2017.02.001_bb0115","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.12659\/MSM.896090","article-title":"Anti-PLA2R antibodies in Chinese patients with membranous nephropathy","volume":"22","author":"Li","year":"2016","journal-title":"Med. Sci. Monit."},{"issue":"2","key":"10.1016\/j.jim.2017.02.001_bb0120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.clim.2007.08.005","article-title":"Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays","volume":"125","author":"Liu","year":"2007","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.jim.2017.02.001_bb0125","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.2337\/db15-1058","article-title":"Identification of Tetraspanin-7 as a target of autoantibodies in type 1 diabetes","volume":"65","author":"McLaughlin","year":"2016","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.jim.2017.02.001_bb0130","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1681\/ASN.2010090967","article-title":"Anti-phospholipase A2 receptor antibody in membranous nephropathy","volume":"22","author":"Qin","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.jim.2017.02.001_bb0135","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.autrev.2015.10.004","article-title":"Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN)","volume":"15","author":"Radice","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.jim.2017.02.001_bb0140","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1086\/589718","article-title":"A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection","volume":"198","author":"Ramanathan","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jim.2017.02.001_bb0145","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1681\/ASN.2014111061","article-title":"Epitope spreading of autoantibody response to PLA2R associates with poor prognosis in membranous nephropathy","volume":"27","author":"Seitz-Polski","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.jim.2017.02.001_bb0150","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ymthe.2004.10.016","article-title":"Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo","volume":"11","author":"Tannous","year":"2005","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.jim.2017.02.001_bb0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1309\/AJCP8QMOY5GLRSFP","article-title":"Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study","volume":"142","author":"Timmermans","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.jim.2017.02.001_bb0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000437236","article-title":"Anti-PLA2R antibodies as a prognostic factor in PLA2R-related membranous nephropathy","volume":"42","author":"Timmermans","year":"2015","journal-title":"Am. J. Nephrol."},{"issue":"24","key":"10.1016\/j.jim.2017.02.001_bb0165","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jim.2017.02.001_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CN108602","article-title":"Anti-PLA2R-associated membranous nephropathy: a review with emphasis on diagnostic testing methods","volume":"84","author":"VanBeek","year":"2015","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.jim.2017.02.001_bb0175","first-page":"73","article-title":"Membranous nephropathy: pilot study of a novel regimen combining cyclosporine and rituximab","volume":"1","author":"Waldman","year":"2016","journal-title":"KIREPORTS"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175916303076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175916303076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T15:21:56Z","timestamp":1536074516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175916303076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":35,"alternative-id":["S0022175916303076"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2017.02.001","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2017.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}